A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines
被引:66
作者:
Matsuguchi, T
论文数: 0引用数: 0
h-index: 0
机构:Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
Matsuguchi, T
Musikacharoen, T
论文数: 0引用数: 0
h-index: 0
机构:Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
Musikacharoen, T
Johnson, TR
论文数: 0引用数: 0
h-index: 0
机构:Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
Johnson, TR
Kraft, AS
论文数: 0引用数: 0
h-index: 0
机构:Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
Kraft, AS
Yoshikai, Y
论文数: 0引用数: 0
h-index: 0
机构:Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
Yoshikai, Y
机构:
[1] Nagoya Univ, Sch Med, Dis Mechanism & Control Res Inst, Lab Host Def & Germfree Life,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Univ Colorado, Hlth Sci Ctr, Dept Med Oncol, Denver, CO 80262 USA
We have isolated a cDNA homologous to known dual-specificity phosphatases from a mouse macrophage cDNA library and termed it MKP-M (for mitogen-activated protein kinase phosphatase isolated from macrophages). Three other presumed splice variant isoforms have also been identified for MKP-M. The longest and most abundant mRNA contains an open reading frame corresponding to 677 amino acids and produces an 80-kDa protein. The deduced amino acid sequence of MKP-M is most similar to those of hVH-5 (or mouse M3/6) and VHP1, a Caenorhabditis elegans tyrosine phosphatase. It includes an N-terminal rhodanase homology domain, the extended active-site sequence motif (V/L)X(V/I)HCXAG(I/V)SRSXT(I/V)XXAY(L/I)M (where X is any amino acid), and a C-terminal PEST sequence. Northern blot analysis revealed a dominant MKP-M mRNA species of approximately 5.5 kb detected ubiquitously among all tissues examined. MKP-M was constitutively expressed in mouse macrophage cell lines, and its expression levels were rapidly increased by lipopolysaccharide (LPS) stimulation but not by tumor necrosis factor alpha (TNF-alpha), gamma interferon, interleukin-2 (IL-2), or IL-15 stimulation. Immunocytochemical analysis showed MKP-M to be present within cytosol. When expressed in COS7 cells, MKP-M blocks activation of mitogen-activated protein kinases with the selectivity c-jun N-terminal kinase (JNK) much greater than p38 = extracellular signal-regulated kinase. Furthermore, expression of a catalytically inactive form of MKP-M in a mouse macrophage cell line increased the intensity and duration of JNK activation and TNF-alpha secretion after LPS stimulation, suggesting that MKP-M is at least partially responsible for the desensitization of LPS-mediated JNK activation and cytokine secretion in macrophages.
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Camps, M
;
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
;
Gillieron, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Gillieron, C
;
Antonsson, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
;
Muda, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Muda, M
;
Chabert, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Chabert, C
;
Boschert, U
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Boschert, U
;
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
;
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
;
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Camps, M
;
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
;
Gillieron, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Gillieron, C
;
Antonsson, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
;
Muda, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Muda, M
;
Chabert, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Chabert, C
;
Boschert, U
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Boschert, U
;
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
;
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
;
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland